CCLG rhabdomyosarcoma project grant

A project grant of up to £125,000 and up to three years is available for a clearly defined research project addressing a key question in ATRT. ATRT is a rare, fast growing tumour that begins in the brain and spinal cord. The funded project will improve our understanding of the disease and help improve the outlook for children diagnosed with ATRT.

The funds for this project have been raised by CCLG Special Named Funds The Joel Prince Starlight Fund and Our Buoy Hugo's Fund.

Our project grants may support stand-alone projects, research that is part of a wider project or trial, or research that is likely to lead to a further, larger grant application to a major funder of research. Basic science/biology, translational or clinical research related to ATRT will be considered, and we would particularly welcome applications for projects which are connected to, or proposed as sub-studies of, the forthcoming clinical trial.

The deadline for applications is 17:00 on Wednesday 14 September 2022. Applications submitted after the deadline will not be accepted. Funding is available to UK and Ireland based research organisations, i.e. universities and hospitals.

Key facts:

  • Clearly defined research project addressing a key question in ATRT
  • Up to £125,000 over a maximum of three years is available
  • Deadline 17:00 on 14 September 2022

Applications will be judged on

  • Scientific quality and impact
  • Relevance
  • Scientific Leadership
  • Justification of resources

Please note, this grant round has a greater focus on the provision of information which is accessible for patients, families and the general public. In the ‘Plain English Summary’ section, we encourage all applicants to write their responses in a form which can be easily understood by a lay audience. Please refer to the lay summary guidance on the CCLG website to ensure your writing meets our expectations. If, during the peer review process, this section is not deemed to be clearly understandable, applicants will be asked to resubmit a new version. 

All applicants are requested to provide a title, accessible outline of their proposed research and an overview of the project strengths which should be easily understood by a lay audience. CCLG is also committed to funding projects which support greater engagement and involvement with patients, families and the general public. All applicants are asked to describe any plans for engagement and involvement with members of the public throughout the various stages of their research project, including proposals for dissemination that are accessible for a lay audience. Specifically, applicants are asked to comment on how these activities can influence and help your research to achieve a greater and broader impact.

For further information, the following external websites may help you with ideas for how to involve members of the public in your research, together with good practice guidelines.

Application Process  

  • All applications should be submitted through our online portal. You will need to sign up for an account with us to complete this process. Applications must be completed by 17:00 on 14 September 2022. 
  • Applications will be awarded through a competitive peer reviewed process (in line with AMRC principles) and a recommendation will be made by our Research Advisory Group (RAG) toto the CCLG Executive who will have final decision on the grants awarded under delegated authority from the CCLG Trustees.
  • Awarded grants will be subject to the CCLG Research Grant Terms and Conditions
  • Informal enquires can be made to Dr Sarah Evans, Research Officer.
  • We would expect final decisions to be made by the end of December 2022, so please plan your proposed start date accordingly. 

Please read our guidance for applicants before starting an application

Guidance for applicants 

Apply now 

How research applications are selected

Excellent research governance is at the heart of our research decision making. Our independent Research Advisory Group (RAG) overseas our research grant rounds and follows our Principles of Peer Review Policy. All of our RAG members and external peer reviewers are asked to declare any Conflicts of Interestand adhere to our Grant Review Code of Conduct . Following peer review, the RAG will discuss and rank the applications for funding. Final approval comes from our Board of Trustees (which may be delegated to our Executive in the case of Special Named Funds and restricted funds).